Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sandoz
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
must be able to speak, read, and understand English
exhaled Nitrous Oxide levels must be greater than or equal to 60 ppb at screening and greater than or equal to 55 ppb at Visits 2, 9, and 16
must have history of at least 6 months of chronic, but stable asthma
except for the presence of asthma, subjects must be in general good health
You may not be if
past or present history of experiencing allergic reaction to medications used in this study
subjects must not be receiving ongoing regular treatment with inhaled corticosteroids
subjects must not have ragweed allergy
subjects must have no recent history of respiratory infections for at least 1 month prior to screening and until the end of the study
Clareo Health | Pilot Study to Examine the Post-Dose Changes in Exhaled Nitric Oxide (eNO) Following Treatment With Fluticasone Propionate (FP)/Salmeterol (SAL) Combination Product Advair
